PAUSHAK LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,325 INR | -0.09% |
|
+3.82% | -12.25% |
| May. 03 | Paushak Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| Apr. 01 | Paushak Limited Announces Cessation of Amit Goradia and Vijay Gandhi as an Independent Directors | CI |
| Sales 2022 | 1.5B 18.01M | Sales 2023 | 2.12B 25.48M | Capitalization | 19.16B 230M |
|---|---|---|---|---|---|
| Net income 2022 | 376M 4.51M | Net income 2023 | 540M 6.48M | EV / Sales 2022 | 21.1 x |
| Net cash position 2022 | 428M 5.13M | Net cash position 2023 | 706M 8.46M | EV / Sales 2023 | 8.69 x |
| P/E ratio 2022 |
85.2
x | P/E ratio 2023 |
35.5
x | Employees | 335 |
| Yield 2022 |
0.12% | Yield 2023 |
0.28% | Free-Float | 28.92% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.09% | ||
| 1 week | +2.66% | ||
| Current month | +2.01% | ||
| 1 month | +2.77% | ||
| 3 months | -1.80% | ||
| 6 months | -10.37% | ||
| Current year | -12.25% |
1 week
5 151.05
5 434.95
1 month
4 850.905 555.00
Current year
4 464.006 230.00
1 year
4 464.007 452.00
3 years
4 464.0012 400.00
5 years
1 301.8012 400.00
10 years
125.0012 400.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 13-04-30 | |
Kirti Shah
DFI | Director of Finance/CFO | - | 19-11-11 |
Chintan Gosaliya
COO | Chief Operating Officer | - | Nov. 01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 76 | 05-08-17 | |
| Director/Board Member | 44 | 06-08-17 | |
| Director/Board Member | 71 | 23-07-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 5,325 | -0.09% | 1,086 |
| 24-05-02 | 5,329 | +2.10% | 3,034 |
| 24-04-30 | 5,220 | +0.92% | 958 |
| 24-04-29 | 5,172 | +0.84% | 1,628 |
| 24-04-26 | 5,129 | -1.12% | 879 |
Delayed Quote Bombay S.E., May 03, 2024 at 06:00 am EDT
More quotes
Paushak Limited is an India-based company, which is engaged in the business of specialty chemicals. The Company is engaged in the business of manufacturing phosgene-based specialty chemicals. The Company serves various industries, such as pharmaceuticals, agrochemicals, performance and custom synthesis. Its product categories include chloroformate, isocyanate, chloride, carbonate/carbamate and others. Its chloroformate products include benzyl chloroformate, ethyl chloroformate, methyl chloroformate and myristyl chloroformate. The Company's isocyanate products include 2-chloro ethyl isocyanate, phenyl isocyanate and stearyl isocyanate. Its chloride products include 3 chloropropionyl chloride, diethyl carbamoyl chloride and dimethyl carbamoyl chloride. The Company's carbonate/carbamate products include polyquaternium, chloromethyl isopropyl carbonate and bis-(4 nitrophenyl) carbonate. Its other products include tetrabutyl urea, vilsmeier reagent and dicyclohexyl carbodiimide.
Sector
Specialty Chemicals
Calendar
2024-05-05
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -12.25% | 197M | |
| +14.70% | 64.83B | |
| -1.61% | 46.29B | |
| +14.58% | 40.05B | |
| +20.84% | 26.72B | |
| +1.16% | 17.45B | |
| -21.87% | 15.82B | |
| +1.11% | 15.02B | |
| -11.34% | 14.73B | |
| -20.82% | 13.34B |
- Stock Market
- Equities
- PAUSHAKLTD6 Stock
